17,20-@LYASE DEFICIENCY, ISOLATED
|
17-@ALPHA-HYDROXYLASE/17,20-LYASE DEFICIENCY, COMBINED COMPLETE
|
17-@ALPHA-HYDROXYLASE/17,20-LYASE DEFICIENCY, COMBINED PARTIAL
|
ADENOMA, CORTISOL-PRODUCING, INCLUD
|
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY
|
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY,
|
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASE
|
ADRENAL INSUFFICIENCY, CONGENITAL, WITH 46,XY SEX REVERSAL, PARTIAL
|
AROMATASE DEFICIENCY
|
BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY
|
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 3
|
BREAST CANCER, SUSCEPTIBILITY TO, INCLUDED
|
CEREBROTENDINOUS XANTHOMATOSIS
|
CLASSIC TYPE
|
CYP2A6*11
|
DEBRISOQUINE, POOR METABOLISM OF
|
DEBRISOQUINE, ULTRARAPID METABOLISM OF
|
DEFICIENCY
|
EFAVIRENZ CENTRAL NERVOUS SYSTEM TOXICITY, SUSCEPTIBILITY TO, INCLUDED
|
EFAVIRENZ, POOR METABOLISM OF
|
GHOSAL HEMATODIAPHYSEAL SYNDROME
|
GLIPIZIDE POOR M
|
HYPERCALCEMIA, INFANTILE
|
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 5
|
MEPHENYTOIN, POOR METABOLISM OF
|
NONCLASSIC TYPE
|
OR COMPLETE
|
PHENYTOIN POOR METABOLIZER, INCLUDED;;
|
PROGUANIL, POOR METABOLISM OF, INCLUDED
|
RADIOHUMERAL FUSIONS WITH OTHER SKELETAL AND CRANIOFACIAL ANOMALIES
|
SALT-WASTING TYPE
|
SPASTIC PARAPLEGIA 56, AUTOSOMAL RECESSIVE
|
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE
|
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE, INCLUDED
|
TEGAFUR, POOR METABOLISM OF
|
TOLBUTAMIDE POOR METABOLIZER
|
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A
|
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B
|
WARFARIN SENSITIVITY
|
WARFARIN SENSITIVITY, INCLUDED;;
|